We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SPL7013

News List

VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant prnasia
July 28, 2021
Starpharma announced new data demonstrating that SPL7013, the antiviral agent in VIRALEZE™ nasal spray, is active against the highly transmissible Delta variant of SARS-CoV-2, achieving more than 99.99% reduction of infectious virus in ...
Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants prnasia
June 18, 2021
New data released today shows that Australia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus.
Starpharma’s SPL7013 shows significant activity against SARS-CoV-2 pharmaceutical-business-review
April 22, 2020
Starpharma announced that its proprietary VivaGel active, astodrimer sodium (SPL7013), has been shown in laboratory studies to have significant antiviral activity against the coronavirus that causes COVID-19 (coronavirus disease).